HIV
News
HIV vaccine trial makes pivotal leap toward making ‘super antibodies’
“The trial results show that one can design vaccines that induce antibodies with prespecified genetic features, and this may herald a new era of...
Conference Coverage
People living with HIV are a model population for vaccination
The PLWH community can still offer valuable insights into effective ways to reach out to people.
Conference Coverage
PrEP education during STI testing could boost HIV protection
It comes down to numbers. More people seek screening for STIs compared with those who actively seek PrEP for HIV prevention.
Conference Coverage
Life expectancy 6.3 years shorter for Black MSM with HIV
“If you can find effective interventions, the effect can be incredibly large. These are very large differences in life-years and life expectancies...
Conference Coverage
Monkeypox presentations, prevention strategies shifting
There’s been a demographic shift in infections from White, non-Hispanic men early on to non-Hispanic Black and Hispanic men.
News
Gardasil 9 HPV vaccine advised for MSM living with HIV
“We are underutilizing the HPV vaccine in our clinical settings in the United States and globally.”
News from the FDA/CDC
FDA approves HIV-1 treatment ibalizumab for 30-second IV push
“The evolution of Trogarzo administration from intravenous infusion to intravenous push means less preparation and treatment time in clinics.”
News
A switch to B/F/TAF keeps HIV suppressed, even with M184V/I mutation
“This combination is recommended as an initial regimen by the U.S. Department of Health & Human Services.”
Conference Coverage
Injectable HIV prevention better than pills in two trials
“The incredible efficacy of long-acting PrEP for cisgender women shown by HPTN 084 is game-changing for our practice.”
Conference Coverage
Landmark ALLIANCE results offer tenofovir guidance in HIV/HBV coinfection
“There is hardly any good reason to give the two-pill DTG regimen over single-tablet BTG/TAF/FTC in HBV-coinfected people living with HIV.”